Russell 2000 U.S. Small-Cap UCITS ETF
Russell 2000 U.S. Small-Cap UCITS ETF - (USD) Accumulating (V2SA)
Related Documents
About this fund
Fund objectives
- In seeking to achieve its investment objective, the Fund aims to provide a return which, before the application of fees and expenses, is similar to the return of the Index.
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the Russell 2000® Index (the “Index”).
- The Index measures the performance of the small-cap segment of the US equity universe. The Index is a subset of the Russell 3000® Index which is designed to represent approximately 98% of the investable US equity market. It includes approximately 2,000 of the smallest securities based on a combination of their market cap and current index membership.
- The Fund attempts to: 1. Track the performance of the Index by fully replicating the Index, so that the Fund invests in all, or substantially all, of the constituents of the Index, making the weight of such investments approximate to those of the Index, to the extent practicable. 2. Remain fully invested except in extraordinary market, political or similar conditions where the Fund may temporarily depart from this investment policy to avoid losses.
Fund facts
Share class inception
07 Jul 2026
Listing date
09 Jul 2026
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Risk indicator
Strategy
Index
Asset Class
Equity
Investment method
Physical
Index ticker
RU2000N
Benchmark
Russell 2000 Index
Dividend schedule
—
Domicile
Ireland
Legal entity
Vanguard Funds PLC
Register countries
United Kingdom, Iceland, Portugal, Malta, Guernsey, C.I., Slovakia, Spain, Czech Republic, Norway, Slovenia, Jersey, C.I., Poland, France, Lithuania, Luxembourg, Romania, Finland, Ireland, Latvia, Cyprus, Estonia, Italy, Liechtenstein, Hungary, Sweden, Switzerland, Austria, Germany, Bulgaria, Denmark, Greece, Isle of Man, Netherlands and Croatia
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
-
Sorry, this information is not available yet. It will display a year after inception date.
Please note Beta and R-squared data will only display for funds with 3 full years of history.
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 1,950 | 1,953 | 31 Aug 2026 |
| Median market capital | 3.7 B | 3.7 B | 31 Aug 2026 |
| 17.7 x | 17.7 x | 31 Aug 2026 | |
| 2.1 x | 2.1 x | 31 Aug 2026 | |
| 6.9% | 6.9% | 31 Aug 2026 | |
| 8.7% | 8.8% | 31 Aug 2026 | |
| Portfolio turnover rate | — | — | — |
Market allocation
As at 31 Aug 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United States of America | North America | 97.62% | 97.29% | 0.33% |
| Canada | North America | 0.80% | — | — |
| Other | Other | 0.71% | 2.37% | -1.66% |
| United Kingdom | Europe | 0.30% | — | — |
| Norway | Europe | 0.16% | — | — |
| Brazil | Emerging Markets | 0.15% | 0.14% | 0.01% |
| Israel | Middle East | 0.05% | 0.04% | 0.01% |
| Panama | Emerging Markets | 0.05% | 0.05% | 0.00% |
| Singapore | Pacific | 0.04% | 0.05% | -0.01% |
| Ireland | Europe | 0.04% | — | — |
| Greece | Europe | 0.02% | — | — |
| Italy | Europe | 0.02% | — | — |
| Australia | Pacific | 0.02% | — | — |
| South Africa | Emerging Markets | 0.01% | — | — |
| China | Emerging Markets | 0.00% | — | — |
Holdings details
As at 31 Aug 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| JFrog Ltd | 0.34970% | Technology | US | US$20,814.56 | 208 |
| Moog Inc | 0.33704% | Industrials | US | US$20,061.00 | 54 |
| UMB Financial Corp | 0.33550% | Financials | US | US$19,969.83 | 141 |
| Glaukos Corp | 0.33184% | Health Care | US | US$19,751.60 | 110 |
| Brinker International Inc | 0.31863% | Consumer Discretionary | US | US$18,965.50 | 83 |
| BrightSpring Health Services Inc | 0.30514% | Health Care | US | US$18,162.40 | 311 |
| Krystal Biotech Inc | 0.30187% | Health Care | US | US$17,968.00 | 50 |
| Cytokinetics Inc | 0.30141% | Health Care | US | US$17,940.23 | 253 |
| Protagonist Therapeutics Inc | 0.29291% | Health Care | US | US$17,434.50 | 118 |
| SM Energy Co | 0.29046% | Energy | US | US$17,288.70 | 465 |
Prices and distribution
Prices
NAV Price (USD)
US$95.11
USDChange
-US$0.56-0.59% At closure 06 Oct 2026
Market value (EUR)
€83.85
Change
-€1.14-1.34% At closure 07 Oct 2026
NAV 52-week high
US$102.94
At closure 07 Oct 2026
Market value 52-week high
€88.82
At closure 07 Oct 2026
NAV 52-week low
US$93.97
At closure 07 Oct 2026
Market value 52-week low
€83.03
At closure 07 Oct 2026
NAV 52-week difference
US$8.97
Change
+8.71% At closure 07 Oct 2026
Market value 52-week difference
€5.79
Change
+6.52% At closure 07 Oct 2026
Outstanding shares
118,741
At closure 30 Sep 2026
Historical Prices
-
Inception date
07 Jul 2026
Listing date
09 Jul 2026
| Date | NAV (USD) | Market price (EUR) |
|---|---|---|
| 07 Oct 2026 | — | €83.8500 |
| 06 Oct 2026 | US$95.1099 | €84.9900 |
| 05 Oct 2026 | US$95.6710 | €85.1700 |
| 02 Oct 2026 | US$95.1912 | €84.6700 |
| 01 Oct 2026 | US$94.3067 | €83.1900 |
| 30 Sep 2026 | US$93.9740 | €83.3100 |
| 29 Sep 2026 | US$94.3170 | €83.0300 |
| 28 Sep 2026 | US$94.6497 | €83.0400 |
| 25 Sep 2026 | US$95.3059 | €83.5700 |
| 24 Sep 2026 | US$95.2375 | €83.1800 |
Distribution history
Distribution frequency
—
Historical performance
—
All dividends are reinvested for the "Accumulation" shares.
Purchase information
Currencies and stock exchanges
Listed currencies: USD, GBP, EUR
Base currency:USD
Exchanges: London Stock Exchange, Deutsche Boerse, Borsa Italiana S.p.A., NYSE Euronext - Amsterdam, SIX Swiss Exchange